BCLI FDA Meeting Provides Clear Path for Planned Phase 3b Trial of NurOwn
| BCLI Stock | USD 1.73 0.02 1.17% |
Under 61% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
Brainstorm |
By David Bautz, PhD NASDAQBCLI READ THE FULL BCLI RESEARCH REPORT Business Update Clear Path Forward for Phase 3b Trial of NurOwn On December 7, 2023, BrainStorm Cell Therapeutics, Inc. announced the company attended a meeting with the U.S. Food and Drug Administration regarding the planned Phase 3b trial for NurOwn in amyotrophic lateral sclerosis . The company is going
Read at finance.yahoo.com
 |
Brainstorm Cell Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Brainstorm Cell Fundamental Analysis
We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Brainstorm Cell is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Brainstorm Cell Ther Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.
Peers
Brainstorm Cell Related Equities
| TERN | Terns Pharmaceuticals | 3.41 | ||||
| GRI | GRI Bio | 3.08 | ||||
| CNTB | Connect Biopharma | 2.78 | ||||
| EWTX | Edgewise Therapeutics | 1.33 | ||||
| CRVS | Corvus Pharmaceuticals | 0.36 | ||||
| CELC | Celcuity LLC | 0.71 | ||||
| ALDX | Aldeyra | 1.66 | ||||
| PLX | Protalix Biotherapeutics | 1.80 | ||||
| DAWN | Day One | 1.81 | ||||
| MREO | Mereo BioPharma | 2.20 | ||||
| CUE | Cue Biopharma | 2.56 | ||||
| TRVI | Trevi Therapeutics | 2.80 | ||||
| GBIO | Generation Bio | 3.52 | ||||
| BCAB | Bioatla | 4.79 | ||||
| HOWL | Werewolf Therapeutics | 5.10 | ||||
| XFOR | X4 Pharmaceuticals | 5.13 | ||||
| CCCC | C4 Therapeutics | 5.58 | ||||
| INZY | Inozyme Pharma | 6.09 | ||||
| ANTX | AN2 Therapeutics | 6.25 | ||||
| CKPT | Checkpoint Therapeutics | 6.26 | ||||
| HCWB | HCW Biologics | 9.80 | ||||
| PASG | Passage Bio | 11.88 |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |